Topiramate in children and adolescents with epilepsy and mental retardation: A prospective study on behavior and cognitive effects

Epilepsy and Behavior

Volumn 12, Issue 2, 2008, Pages 253-256

  Coppola, Giangennaro ^a   Verrotti, Alberto ^b   Resicato, Gianluca ^a   Ferrarelli, Silvia ^a   Auricchio, Gianfranca ^a   Operto, Francesca Felicia ^a   Pascotto, Antonio ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

Author keywords

Behavior; Cognition; Epilepsy; Mental retardation; Topiramate

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLOBAZAM; ETHOSUXIMIDE; FELBAMATE; LAMOTRIGINE; PHENOBARBITAL; TOPIRAMATE; VALPROIC ACID; VIGABATRIN;

ADD ON THERAPY; ADOLESCENT; ADULT; AGGRESSIVENESS; ALERTNESS; ANTICONVULSANT THERAPY; ARTICLE; BEHAVIOR DISORDER; CAREGIVER; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITIVE DEFECT; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DECREASED APPETITE; DISEASE SEVERITY; DROWSINESS; DRUG WITHDRAWAL; EPILEPSY; FATIGUE; FEMALE; FOCAL EPILEPSY; FOLLOW UP; GENERALIZED EPILEPSY; HUMAN; INSOMNIA; IRRITABILITY; MALE; MENTAL CONCENTRATION; MENTAL DEFICIENCY; MONOTHERAPY; PARENT; PSYCHOSIS; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; SEIZURE; SIDE EFFECT; SYMPTOMATOLOGY;

ADOLESCENT; ADULT; ANTICONVULSANTS; BEHAVIOR; CHILD; CHILD, PRESCHOOL; COGNITION DISORDERS; DRUG THERAPY, COMBINATION; EPILEPSY; FEMALE; FRUCTOSE; HUMANS; MALE; MENTAL DISORDERS; MENTAL RETARDATION; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 37749048131     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2007.09.001     Document Type: Article

References (20)

1. Biton V., Bourgeois B.F., and YTC/YTCE Study Investigators. Topiramate in patients with juvenile myoclonic epilepsy. Arch Neurol 62 (2005) 1705-1708
2. Coppola G., Caliendo G., Terracciano M.M., Buono S., Pellegrino L., and Pascotto A. Topiramate in refractory partial-onset seizures in children, adolescents and young adults: a multicentric open trial. Epilepsy Res 43 (2001) 255-260
3. Coppola G., Caliendo G., Veggiotti P., et al. Topiramate as add-on drug in children, adolescents and young adults with Lennox-Gastaut sindrome: an Italian multicentric study. Epilepsy Res 51 (2002) 147-153
4. Coppola G., Capovilla G., Montagnini A., et al. Topiramate as add-on drug in severe myoclonic epilepsy in infancy: an Italian multicenter open trial. Epilepsy Res 49 (2002) 45-48
5. Dooley J.M., Camfield P.R., Smith E., Langevin P., and Ronen G. Topiramate in intractable childhood onset epilepsy: a cautionary note. Can J Neurol Sci 26 (1999) 271-273
6. Elterman R.D., Glauser T.A., Wyllie E., Reife R., Wu S.C., Pledger G., and the Topiramate YP Study Group. A double-blind, randomized trial of topiramate as adjunctive therapy for partial-onset seizures in children. Neurology 52 (1999) 1338-1344
7. Glauser T.A., Clark P.O., and Strawsburg R. A pilot study of topiramate in the treatment of infantile spasms. Epilepsia 39 (1998) 1324-1328
8. Glauser T.A., Levishon P.M., Ritter F., Sachdeo R.C., and the Topiramate YL Study Group. Topiramate in Lennox-Gastaut syndrome: open-label treatment of patients completing a randomized controlled trial. Epilepsia 41 Suppl. 1 (2000) S86-S90
9. Grosso S., Franzoni E., Iannetti P., et al. Efficacy and safety of topiramate in refractory epilepsy of childhood: long-term follow-up study. J Child Neurol 20 (2005) 893-897
10. Guerrini R., and Parmeggiani L. Topiramate and its clinical applications in epilepsy. Expert Opin Pharmacother 7 (2005) 811-823
11. Mohamed K., Appleton R., and Rosenbloom L. Efficacy and tolerability of topiramate in childhood and adolescent epilepsy: a clinical experience. Seizure 9 (2000) 137-411
12. Nieto-Barrera M., Candau R., Nieto-Jimenez M., Correa A., and Ruiz del Portal L. Topiramate in the treatment of severe myoclonic epilepsy in infancy. Seizure 9 (2000) 590-594
13. Uldall P., and Buchholt J.M. Clinical experience with topiramate in children with intractable epilepsy. Eur J Paediatr Neurol 3 (1999) 105-111
14. Wheless J.W. Use of topiramate in childhood generalized seizure disorders. J Child Neurol 15 Suppl. 1 (2000) S7-S13
15. Bourgeois B.F.D. Pharmacokinetics and pharmacodynamics of topiramate. J Child Neurol 15 (2000) S27-S30
16. Zhang X., Velumian A.A., Jones O.T., and Carlen P.L. Modulation of high-voltage-activated calcium channels in dentate granule cells by topiramate. Epilepsia 41 (2000) S52-S60
17. Aldenkamp A.P., Alpherts W.C.J., Blennow G., et al. Withdrawal of antiepileptic medications: effects on cognitive function in children-the results of the multicentre "Holmfrid" study. Neurology 43 (1993) 41-51
18. Moreland E.C., Griesemer D.A., and Holden K.R. Topiramate for intractable childhood epilepsy. Seizure 8 (1999) 38-40
19. Gerber P.E., Hamiwka L., Connolly M.B., and Farrell K. Factors associated with behavioural and cognitive abnormalities in children receiving topiramate. Pediatr Neurol 22 (2000) 200-203
20. Aldenkamp A.P., Alpherts W.C.J., Sandstedt P., et al. Antiepileptic drug-related cognitive complaints in seizure-free children with epilepsy before and after drug discontinuation. Epilepsia 39 (1998) 1070-1074